Digital health platforms powered by AI, real-world data (RWD), cancer registries, and patient-reported outcomes (PROs) are transforming cancer care by enhancing treatment analysis, improving patient experience, and bridging gaps in care access across diverse healthcare settings. Learn how the industry bridges technology and compassionate care to enhance oncological care and treatment outcomes.
Download
Cancer care isn’t limited to the patient's treatment; it also focuses on their emotional and physical well-being as they navigate their unique journey. It’s a complex process unique to oncology that requires health systems to blend effective treatment with compassionate care.
Thankfully, cancer registries, real-world data (RWD), and patient-reported outcomes (PROs) help providers better understand the patient experience. Additionally, with emerging advanced technologies such as AI and predictive analytics, the industry is witnessing a transformation in how providers deliver cancer care.
The rise of real-world data, gathered from administrative sources such as claims and EHRs, has created expansive datasets for analyzing patient experiences. However, traditional data streams have limitations, particularly in oncology, where critical insights about symptoms, quality of life, and treatment side effects are often missing.
To bridge this gap, digital health technologies, such as remote patient monitoring and patient-reported outcomes tools, have become valuable resources. Coupled with the data that a cancer registry provides—real-time, systematic data on diseases, treatments, and patient experiences beyond controlled clinical trial settings—digital health technologies connect real-world data to capture how patients respond to therapy in everyday healthcare environments.
This connection between digital health solutions and cancer registry data improves patient satisfaction, quality of life, treatment experiences, and even survival outcomes while reducing hospitalizations, emergency visits, and unnecessary office visits.
One of the primary challenges when dealing with cancer patient data is the complexity of extracting meaningful insights from EHRs and other administrative data sources. EHRs are primarily designed for reimbursement and care tracking rather than research, making it challenging to structure the data for analytical purposes.
Another major challenge in oncology is that critical aspects of the cancer experience—such as genomic and biomarker data—are often missing from traditional data sources. Additionally, key indicators like disease progression, treatment response, and mortality are usually embedded in free-text clinical notes rather than structured fields, necessitating advanced analytics capabilities, such as natural language processing (NLP), to extract meaningful insights.
More importantly, beyond clinical data lies the importance of understanding patient quality of life, an especially critical factor in oncology given the severity of diagnoses and potential adverse symptoms associated with treatments.
Cancer care management platforms are instrumental in bridging care gaps between large academic centers and small rural institutions by acting as a “force multiplier” for care teams. In rural areas, where patients may live far from treatment centers and have difficulty traveling frequently, these platforms enable ongoing communication with care teams, ensuring more regular patient monitoring without requiring in-person visits.
Beyond improving access, these platforms also facilitate broader data collection and analysis, allowing for better comparisons of treatment and symptom management patterns across diverse healthcare settings. By deploying digital tools widely, providers and administrators can enhance care coordination, reduce disparities in access, and support research into how treatment experiences differ based on location and healthcare infrastructure.
AI is a powerful tool in processing and analyzing disparate healthcare data sources within cancer care solutions. These platforms can provide frequent and structured patient-reported data, which enhances the ability to train and update AI models dynamically.
This ongoing data collection allows machine learning algorithms to become more accurate over time, improving their ability to identify patterns and make actionable predictions. For example, AI can help detect which patients struggle to continue a given oncology therapy, require additional management and outreach, or are better suited for an alternative treatment.
As healthcare data grows in variety and frequency, AI’s role in clinical decision-making in cancer care will become increasingly valuable. Machine learning models will improve in precision, ultimately making AI-driven insights more actionable for patient care and a critical tool in advancing personalized medicine, optimizing treatment paths, and ensuring that interventions are more targeted and effective.
To truly understand real-world healthcare data, it’s essential to consider patient experiences and insights, known as patient-reported outcomes (PROs).
PROs can provide a validated, reliable, and repeatable method for assessing patient well-being over time and prove significant in measuring and quantifying the subjective nature of patient experiences. PROs introduce quantitative objectivity to what has traditionally been seen as a qualitative issue, allowing healthcare providers and researchers to track improvements, identify challenges, and assess the effectiveness of interventions to enhance patient care.
Historically, PRO data were primarily collected in clinical trials or large registries, limiting their applicability to real-world patient care. However, digital health technologies have revolutionized the field by integrating PROs into routine clinical practice.
By doing so, healthcare teams can now systematically capture patient experiences in real-world settings, facilitating better decision-making and research. This allows direct comparisons between patient experiences in clinical trials and everyday healthcare environments. As a result, stakeholders can help determine whether trial-based benefits hold true for a broader, more diverse patient population.
Ultimately, PROs are crucial tools for improving patient-centered care, enabling a deeper understanding of treatment effects and ensuring that patient voices are incorporated into clinical practice and health outcomes research.
Every advancement in oncology, when fused with innovative technologies, cancer registries, and patient-reported outcomes, yields deeper insights into patient experience and treatment outcomes. This wealth of information transforms how cancer care is delivered, leading to more tailored treatment, improved quality of life, increased survival rates, and improved patient experience.
Would you like to learn more? Here is additional content we suggest:
Episode 33: A Conversation with Aaron Galaznik, Chief Science Officer, Carevive by Health Catalyst
Top Five Issues Troubling Healthcare Data Management – And How to Solve Them
New Data and Analytics Ecosystem Unveiled Amid Complex Landscape
From Analytics to Action: How Modern Data Ecosystems Are Shaping Healthcare
